Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Watt

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
JAMA Internal Medicine|February 19, 2019
Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016Louise K Francois Watkins, Lesley McGee, Stephanie J Schrag, et al.
Journal of the American College of Cardiology|May 26, 2026
Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular riskKausik K Ray, Nicholas Clarke, Peter Thornton, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021Tomás M León, Vajeera Dorabawila, Lauren Nelson, et al.
Emerging Infectious Diseases|February 26, 2014
Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012Jonathan J Núñez, Curtis L Fritz, Barbara Knust, et al.
Health Affairs (Project Hope)|May 12, 2021
Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In CaliforniaMarissa B Reitsma, Anneke L Claypool, Jason Vargo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Identification of metabolites of a substance P (neurokinin 1 receptor) antagonist in rat hepatocytes and rat plasmaCornelis E C A Hop, Yanfeng Wang, Sanjeev Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptorS Patel, S Freedman, K L Chapman, et al.
Radiation Research|August 17, 2023
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation TherapyGordon P Watt, Susan A Smith, Rebecca M Howell, et al.
Journal of Medicinal Chemistry|June 23, 1999
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profilesM B van Niel, I Collins, M S Beer, et al.
JACC. Cardiooncology|October 4, 2021
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE StudyLauren E Carlson, Gordon P Watt, Emily S Tonorezos, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
JAMA Internal Medicine|February 19, 2019
Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016Louise K Francois Watkins, Lesley McGee, Stephanie J Schrag, et al.
Journal of the American College of Cardiology|May 26, 2026
Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular riskKausik K Ray, Nicholas Clarke, Peter Thornton, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021Tomás M León, Vajeera Dorabawila, Lauren Nelson, et al.
Emerging Infectious Diseases|February 26, 2014
Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012Jonathan J Núñez, Curtis L Fritz, Barbara Knust, et al.
Health Affairs (Project Hope)|May 12, 2021
Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In CaliforniaMarissa B Reitsma, Anneke L Claypool, Jason Vargo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Identification of metabolites of a substance P (neurokinin 1 receptor) antagonist in rat hepatocytes and rat plasmaCornelis E C A Hop, Yanfeng Wang, Sanjeev Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptorS Patel, S Freedman, K L Chapman, et al.
Radiation Research|August 17, 2023
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation TherapyGordon P Watt, Susan A Smith, Rebecca M Howell, et al.
Journal of Medicinal Chemistry|June 23, 1999
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profilesM B van Niel, I Collins, M S Beer, et al.
JACC. Cardiooncology|October 4, 2021
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE StudyLauren E Carlson, Gordon P Watt, Emily S Tonorezos, et al.
Pageof 22